Healthcare
Live Price
Offline$10.42
+7.87% today
1Y Change
+156.23%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
4D Molecular Therapeutics, Inc. (FDMT) is a Healthcare stock with a market cap of $540.00M and listed on NASDAQ. The stock last traded around $10.42 and up 156.2% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +230194.6%, EPS growth of +18.8%, a dividend yield of 0.0%. What stands out right now is revenue +230194.6%, EPS +18.8%, free cash flow +21.2% with operating margin -187.2% and ROIC -30.2%. Valuation sits in the middle of the pack at price/sales 6.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines FDMT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
FDMT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
FDMT Max Drawdown
-41.40%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for FDMT and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.